DocDollars

E.R. Squibb & Sons, L.L.C.

NJ · United States · Reporting entity ID 100000005499

Total reported 2019–2025
$1.65B
#12 of 2,960 reporting companies — 2% of all reported industry payments
$180.2M in general payments across 1,135,608 records, plus $1.47B in research funding across 34,269 records.

How it breaks down

General payments $180,238,663
Research funding $1,467,545,952

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

E.R. Squibb & Sons, L.L.C. reported $1.65B to US doctors and teaching hospitals from 2019 to 2025, ranking #12 of 2,960 reporting companies. 89% of that was research funding and 11% general payments such as consulting, speaking, food and travel. 1,135,608 general payment records and 34,269 research records were filed.

Common questions about E.R. Squibb & Sons, L.L.C.

How much has E.R. Squibb & Sons, L.L.C. paid US doctors?

E.R. Squibb & Sons, L.L.C. reported $1,647,784,615 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $180,238,663 in general payments, $1,467,545,952 in research funding.

How does E.R. Squibb & Sons, L.L.C. rank among drug and device companies?

It ranks #12 of 2,960 reporting entities by total reported value, about 2% of all industry payments in the dataset.

Does a payment from E.R. Squibb & Sons, L.L.C. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.